| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ORMP ORAMED PHARMACEUTICALS INC. | SALE Chief Financial Officer | 73,360 | $4.51 | $330.7K | 671,785 | Jul 1, 2026 | Jul 2, 2026 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 95,889 | — | — | 745,145 | Mar 17, 2026 | Mar 18, 2026 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | SALE Chief Financial Officer | 19,000 | — | — | 0 | Jan 22, 2026 | Jan 29, 2026 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASE Chief Financial Officer | 19,000 | — | — | 649,256 | Jan 22, 2026 | Jan 29, 2026 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 81,216 | — | — | 515,256 | Dec 31, 2025 | Jan 2, 2026 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 19,000 | — | — | 19,000 | Dec 31, 2025 | Jan 2, 2026 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 115,000 | — | — | 630,256 | Dec 31, 2025 | Jan 2, 2026 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 42,000 | — | — | 434,040 | Feb 11, 2025 | Feb 11, 2025 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 34,000 | — | — | 392,040 | Feb 11, 2025 | Feb 11, 2025 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 188,000 | — | — | 358,040 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 170,040 | Nov 7, 2024 | Nov 8, 2024 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 140,040 | — | — | 0 | Jun 21, 2024 | Jun 21, 2024 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Feb 3, 2021 | Feb 8, 2021 ↗ | View → |